NDC11 68682030030
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 68682-0300-30 | 68682-0300 |
| 68682-300-30 | 68682-300 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clindamycin Phosphate 1.2% and Tretinoin 0.025% | CLINDAMYCIN PHOSPHATE AND TRETINOIN | Oceanside Pharmaceuticals | 63b2e85d-8fe5-4f18-9e85-8492c49a7520 | 2020-04-01 | Warnings, Adverse reactions | 68682-300-30 68682-300 68682030030 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.